Pharmaceuticals Directory Resources

Submit URL Pharmaceuticals

Pharmaceuticals News

Patheon Reaches Agreement With BSP Pharmaceuticals For Development And Manufacture Of Cytotoxics (PharmaceuticalOnline)

Patheon has completed a shareholders agreement and a sales and marketing agreement with Italy's BSP Pharmaceuticals.

OSI Pharmaceuticals Announces Conversion Period for Convertible Notes (Fox News)

OSI Pharmaceuticals Announces Conversion Period for Convertible Notes

Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share (Finanzen.net)

Bentley Pharmaceuticals, Inc. ("Bentley”) (NYSE: BNT) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd. ("Teva”) has been adjusted in accordance with the merger agreement after ...

Wyeth Pharmaceuticals-Progenics drug Relistor OK'd in Europe (BizJournals)

Wyeth Pharmaceuticals and Progenics Pharmaceuticals Inc. received marketing approval from the European Commission Thursday for Relistor, a treatment of opioid-induced constipation in advanced illness patients who are receiving palliative care. (WYE) (PGNX)

Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share (Centre Daily Times)

Bentley Pharmaceuticals, Inc. ("Bentley") (NYSE: BNT) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd. ("Teva") has been adjusted in accordance with the merger agreement after completion of the previously announced taxable spin-off of its drug delivery business, CPEX Pharmaceuticals, Inc. ("CPEX")(NASDAQ: CPEX). Bentley stockholders will ...